Chimeric Antigen Receptor News and Research

RSS
High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

High-risk lymphoma patients may receive durable benefit from axi-cel CAR T cell therapy

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Researchers test a neoantigen-specific transgenic immune cell therapy for malignant gliomas

Researchers test a neoantigen-specific transgenic immune cell therapy for malignant gliomas

New gel enhances immunotherapy's effectiveness in glioblastoma

New gel enhances immunotherapy's effectiveness in glioblastoma

Clinical efficacy of CAR-T cells depends on chemical modifications, says study

Clinical efficacy of CAR-T cells depends on chemical modifications, says study

Novel Assay Platform for 3D Microfluidic Cancer Research

Novel Assay Platform for 3D Microfluidic Cancer Research

Researchers engineer CAR T cells to enhance their function

Researchers engineer CAR T cells to enhance their function

Researchers develop heat-controllable CAR T cells to kill tumors and prevent relapse

Researchers develop heat-controllable CAR T cells to kill tumors and prevent relapse

Mayo Clinic researchers examine potential new CAR-T cell treatment for multiple myeloma

Mayo Clinic researchers examine potential new CAR-T cell treatment for multiple myeloma

Small molecular changes can have dramatic impact on the CAR T cell function

Small molecular changes can have dramatic impact on the CAR T cell function

Researchers use mathematical modeling to explain CAR T-cell therapy dynamics

Researchers use mathematical modeling to explain CAR T-cell therapy dynamics

Study advances CAR T cell therapy targeted at cancer

Study advances CAR T cell therapy targeted at cancer

Engineered safety switch reduces CAR-T immunotherapy-related side effects

Engineered safety switch reduces CAR-T immunotherapy-related side effects

New CAR T therapy could be more effective and less toxic against neuroblastoma

New CAR T therapy could be more effective and less toxic against neuroblastoma

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Researchers create molecular ON-OFF switches to regulate CAR T cell activity

Researchers identify a vital protein needed to regulate anti-tumor immune response

Researchers identify a vital protein needed to regulate anti-tumor immune response

Combination method can boost immunotherapy for breast cancer

Combination method can boost immunotherapy for breast cancer

Study: CAR T cell therapy is a safe, effective therapy for high-risk large B-cell lymphoma

Study: CAR T cell therapy is a safe, effective therapy for high-risk large B-cell lymphoma

Researchers target pathogenic T cells that could lead to new immunotherapy treatments

Researchers target pathogenic T cells that could lead to new immunotherapy treatments

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.